Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Ticker ZBH · NYSE · DE
ZIMMER BIOMET HOLDINGS, INC. is a U.S. business entity operating within the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector (SIC 3842). Publicly traded on the NYSE under the ticker symbol ZBH, the company is incorporated in Delaware. Based on SEC EDGAR filings, ZBH reported fiscal year 2025 revenue of $8.23B, reflecting a year-over-year growth of 7.2%. Our proprietary Semantic Risk Score of 14 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 3842 classification, ZIMMER BIOMET HOLDINGS, INC. serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
ZIMMER BIOMET HOLDINGS, INC. (ZBH) — Key efficiency & solvency metrics · FY2025
Operating Margin
Sector avg: -21.4%
Net Margin
Sector avg: -55.92%
Debt-to-Equity
Sector avg: -10.65
Current Ratio
Sector avg: 3.58
| Key Metric | Company | Industry Avg | Status |
|---|---|---|---|
| Total RevenueYoY: +7.2% | $8.23B | $1.53B | ▲ Outperform |
| Net IncomeYoY: -22% | $705.1M | — | — |
| Operating MarginOperating income as % of revenue | 13.3% | -21.4% | ▲ Outperform |
| Net MarginNet income as % of revenue | 8.6% | -55.92% | ▲ Outperform |
| Debt-to-EquityTotal liabilities / stockholders equity. Lower = safer. | 0.82 | -10.65 | ▼ Leveraged |
| Current RatioCurrent assets / current liabilities. Above 1.0 = solvent. | 1.98 | 3.58 | ▼ Lagging |
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 26 companies in SIC 3842.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
Federal Contracts
SUPPLIES 19-GIMC-PERIOPERATIVE - SUPPLIES VENDOR ZIMMER BIOMET SOUTHWEST - BPA SET UP FOR PURCHASE OF ORTHOPEDIC IMPLANTS INSTRUMENTS SUPPLIES PERIOD OF PERFORMANCE JANUARY 01 2019 TO DECEMBER 31 2019
4562346171!VIEWLINE
EXPRESS REPORT FOR PROSTHETICS ORDERS FOR FY12 589-2P9205 589-2PE636 589-2PE649 589-2PE650 589-2PF232 589-2PF575 589-2PG069 589-2PG070 589-2PG079 589-2PJ704 589-2PK069 589-2PK145 589-2PK648 589-2PK724
MICRO-FIXATION TRAY
EXPRESS REPORT: PROSTHETICS ZIMMER BIOMET PRODUCTS.
EXPRESS REPORT PROSTHETICS PO'S OCT/NOV FY13 589-3P1406 589-3P1418 589-3P1471 589-3P2074 589-3P2707 589-3P3160 589-3P3163 589-3P3634 589-3P3657 589-3P3660 589-3P4412
EXPRESS REPORT: ZIMMER BIOMET TOTAL KNEEE/HIP IMPLANTS
EXPRESS REPORT IMPLANT
EXPRESS REPORT IMPLANT
ZIMMER BIOMET G7 HIP SURGICAL INSTRUMENT KIT
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Compared to 34 peers in Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Revenue
Net Margin
SEC EDGAR XBRL filings by fiscal year
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →